Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The following script is from "Killing Cancer" which aired on March 29, 2015. ..... Scott Pelley: Help me put immunotherapy in perspective here. How big ...
Four decades later, immunotherapy is also the subject of 60 Minutes' latest story produced by Michael Radutzky and Denise Cetta, about promising ...
The results showed that women who did not receive immunotherapy had cancer recurrence over a median of 14.5 months; the majority of those who ...
The immunotherapy is approved for patients with metastatic squamous non-small cell lung cancer with progressed disease on or after being treated ...
According to Duke, researchers 'looked for a way to prime the immune system to be on high alert' before administering the cancer vaccine.
... present, detailing the newest prospects for attacking cancer, the most promising being the harnessing of the immune system to defeat the disease.
"The results from this clinical trial suggest that using a patient's immune system to fight advanced ovarian cancer may be a promising avenue to ...
The chance of a cure is high if the cancer is detected early enough, but ... If we are affected by cancer, our immune system responds to this and tries to ...
Zinc affects how the immune system responds to stimulation and inflammation. Research from Oregon State University shows that zinc deficiency ...
According to a team of scientists from the World Cancer Research Fund ... a strong evidence that links coffee consumption with a lower risk of liver cancer. ... that certain compounds found in coffee can strengthen the immune system.
Los Angeles, California - Scientists at UCLA's California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their ...
The following script is from "Killing Cancer" which aired on March 29, 2015. ... The long war on cancer has left us well short of victory. ..... cancers, colorectal cancers, prostate cancers, pancreatic cancers, liver cancers, renal cancers.
How bullish are big drug makers on cancer immunotherapy these days? Take a ... That trial in pancreatic cancer will compare the CRS-207 and GVAX ...
The origin of many of these treatment breakthroughs: National Cancer .... the more difficult-to-treat malignancies, including lung and pancreatic cancer.
If you had cancer, would you want to make clones of your tumour? ... She was diagnosed with advanced pancreatic cancer in August 2013, at the age.
One of the trials at this company comprises of Phase 2b trial in which the pancreatic cancer treatment developed by Pharmacyte Biotech is compared ...
28 Doctors, 11 Scientists, 9 Survivors And 1 "FDA Dragon Slaying" Attorney Break Their 'Code Of Silence' And Expose The TRUTH About Cancer And Exactly How To Prevent, Treat And Beat it 100% Naturally
MADRID — Chemohyperthermia, which combines bladder heating with intravesical chemotherapy, is more effective in the treatment of intermediate- ...
Renal and Urology News
A new systematic review and meta-analysis confirms an association between obesity and bladder cancer. Pre-obese individuals also may be at risk.
Certainly, bladder cancer can occur at any age, but it's more common in older men and much less frequently an issue in younger men and women.
A phase 2 clinical study of HS-410 for the treatment of non muscle invasive bladder cancer is also underway - with patient enrollment of the first three ...
Science Daily Cancer News
Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.
Researchers are developing molecules that bind to more than 60 types of cancer. Several are being tested in early-stage clinical trials, including one for brain cancer. These custom-made molecules can carry either a "flag" that shines brightly in standard medical scanners or a bit of radiation to kill the targeted cancer cells.
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.
A potential drug molecule has been discovered that stops cancer cells, but not healthy ones, from getting their 'mail.' The average living cell needs communication skills: It must transmit a constant stream of messages quickly and efficiently from its outer walls to the inner nucleus, where most of the day-to-day decisions are made. But this rapid, long-distance communication system leaves itself open to mutations that can give rise to a "spam attack" that promotes cancer, the researchers say.
Early stage non-small cell lung cancer patients with low tumor metabolic activity have longer survival
Low pre-surgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer is associated with increased overall survival and a longer time before tumor recurrence, a study shows. Patients with high labeled glucose uptake may benefit from additional therapy following surgery.
A new drug that shows potential in laboratory studies against a rare type of acute leukemia has been developed by scientists. And additional studies suggest the same compound could play a role in prostate cancer treatment as well, they say.
A large pilot study of a new bowel cancer screening test has demonstrated a major increase in participation rates across population groups. The new test is called a Fecal Immunochemical Test or FIT for short. In addition to being able to detect many more cancers and pre-cancers, the pilot of FIT in 40,000 people in the northwest, midlands and the south of England showed almost double the uptake with FIT than with the current test (guaiac faecal occult blood test or gFOBt) for those who had previously chosen not to participate (14.5 per cent climbed to 25.6 per cent).
Tambahkan Komentar